Examining the role of insulin-like growth factor 1 in the pathophysiology of carpal tunnel syndrome: a Mendelian randomization study
International Journal of Epidemiology · 18.08.2026 · 55 (5)
DOI: 10.1093/ije/dyag173 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Epidemiology, online erschienen am 27.08.2026. Verfasst von Alex J Wood und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom. Hauptthemen laut MEDLINE: Carpal Tunnel Syndrome, Insulin-Like Growth Factor I, Diabetes Mellitus, Type 2, Obesity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Arthritis UK Career Development Fellowship, Kennedy Trust for Rheumatology Research.
Abstract (Originalsprache)
Background
Carpal tunnel syndrome (CTS) is a common and disabling condition of the hand, affecting up to 10% of the population, caused by compression of the median nerve at the wrist. Conventional observational epidemiological studies have demonstrated associations between CTS and elevated plasma insulin-like growth factor 1 (IGF-1), as well as several metabolic factors, such as obesity and type 2 diabetes (T2DM).
Methods
Here, we use two-sample univariable and multivariable Mendelian randomization to investigate causality in the relationships between IGF-1, metabolic factors related to IGF-1, and CTS.
Results
We replicate the result that increases in measures of obesity (body mass index (BMI), waist-hip ratio (WHR), and waist circumference (WC)) are causal for CTS, and show that the effect of elevated childhood BMI on increasing risk of CTS is mediated mostly by elevated adult BMI. Furthermore, we demonstrate that T2DM and raised fasting plasma glucose are also causal for CTS. Finally, we show that increased IGF-1 signalling is also causally related to CTS risk, and the effect is likely mediated by its effects on both BMI and T2DM. The IGF-1 pathway merits further investigation as a potential therapeutic target for CTS.
Conclusion
We provide genetic epidemiological evidence to support obesity, T2DM, and elevated plasma IGF-1 concentrations playing a causal role in increasing the risk of CTS. These findings suggest that pharmacological management of the metabolic risk factors may also decrease the risk of CTS, with the IGF-1 pathway as a potential therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.
- Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
- Department of Urology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
- College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
- Department of Plastic Surgery, Oxford University Hospitals Trust, Oxford, United Kingdom.
ORCID-Profile: Alex J Wood, Dominic Furniss, Akira Wiberg
Förderung
- Arthritis UK Career Development Fellowship
- Kennedy Trust for Rheumatology Research
Zitieren
APA
Wood, A. J., Lovegrove, C. E., Furniss, D., & Wiberg, A. (2026). Examining the role of insulin-like growth factor 1 in the pathophysiology of carpal tunnel syndrome: a Mendelian randomization study. International Journal of Epidemiology, 55(5). https://doi.org/10.1093/ije/dyag173
Vancouver
Wood AJ, Lovegrove CE, Furniss D, Wiberg A. Examining the role of insulin-like growth factor 1 in the pathophysiology of carpal tunnel syndrome: a Mendelian randomization study. International Journal of Epidemiology. 2026;55(5). doi:10.1093/ije/dyag173
BibTeX
@article{Wood2026,
author = {Wood, Alex J and Lovegrove, Catherine E and Furniss, Dominic and Wiberg, Akira},
title = {Examining the role of insulin-like growth factor 1 in the pathophysiology of carpal tunnel syndrome: a Mendelian randomization study},
journal = {International Journal of Epidemiology},
year = {2026},
volume = {55},
number = {5},
doi = {10.1093/ije/dyag173}
}
EUVIMED